Literature DB >> 29099118

Relationship of hyperuricemia with low density lipoprotein , liver function tests and markers of systemic inflammation in patients with morbid obesity.

José Israel León-Pedroza1, Galileo Escobedo2, Antonio González-Chávez1.   

Abstract

Objective: To examine the relationship of uric acid levels with parameters of systemic inflammation, metabolic dysfunction as well as anthropometric parameters and liver function tests in subjects with morbid obesity.
Methods: C-reactive protein (CRP), tumour necrosis factor-alpha, and interleukin 10 (IL-10) were analyzed in 49 women and men with morbid obesity, relating these markers with uric acid, hepatic function tests, anthropometric and metabolic parameters. Metabolic parameters as serum glucose level, glycosylated hemoglobin, total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein (c-LDL) as well as hepatic function parameters were measured in all subjects.
Results: -Comparing subjects with morbid obesity without hyperuricemia versus subjects with morbid obesity and hyperuricemia, an increase of total bilirubin values and gamma glutamil trans peptidase (GGT) was observed, suggesting hyperuricemia as associated with alteration of hepatic metabolism. Serum uric acid levels were statistically correlated with c-LDL, total bilirubin, albumin, GGT and CRP suggesting hyperuricemia could be associated with a dyslipidemic state, hepatic damage and increase in acute pro-inflammatory phase markers. In addition, a multiple linear regression analysis revealed that GGT and IL-10 were better predictors of the behavior of uric acid in the study population.
Conclusion: These results suggest an -interdependent relationship among serum uric acid, CRP and IL-10 levels, which could be related to early hepatic -damage. Copyright:
© 2017 SecretarÍa de Salud

Entities:  

Keywords:  C-reactive protein; Hepatic damage; Hyperuricemia; Morbid obesity; Systemic inflammation

Mesh:

Substances:

Year:  2017        PMID: 29099118     DOI: 10.24875/GMM.17000006

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  4 in total

1.  Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality.

Authors:  Osman Sütcüoğlu; Orhun Akdoğan; Bediz Kurt İnci; Fatih Gürler; Nuriye Özdemir; Ozan Yazıcı
Journal:  Support Care Cancer       Date:  2020-06-25       Impact factor: 3.603

2.  The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study.

Authors:  Jing Liang; Yutong Jiang; Yefei Huang; Wei Song; Xiaomin Li; Yulan Huang; Jiayong Ou; Qiujing Wei; Jieruo Gu
Journal:  Lipids Health Dis       Date:  2020-03-03       Impact factor: 3.876

3.  Nonlinear relationship between serum uric acid and body mass index: a cross-sectional study of a general population in coastal China.

Authors:  Hui Zhou; Zhen Liu; Zhong Chao; Yeqing Chao; Lidan Ma; Xiaoyu Cheng; Yangang Wang; Changgui Li; Ying Chen
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531

4.  Excess serum uric acid is associated with metabolic syndrome in obese adolescent patients.

Authors:  Christy Foster; Loretta Smith; Ramin Alemzadeh
Journal:  J Diabetes Metab Disord       Date:  2020-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.